Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Witzig

Showing results (31-40 of 387) with videos related to

Pageof 39
Sort By:
Medicine|July 16, 2003
Gamma-heavy chain disease: review of 23 casesDietlind L Wahner-Roedler, Thomas E Witzig, Laura L Loehrer, et al.
Blood|April 26, 2003
Expression of CD52 on plasma cells in plasma cell proliferative disordersShaji Kumar, Teresa K Kimlinger, John A Lust, et al.
Leukemia & Lymphoma|November 29, 2013
Therapeutic options for patients with lymphoma and liver dysfunction or failure during mechlorethamine shortageMohamad Bassam Sonbol, Vishal Rana, S Sirop Kenderian, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 20, 2016
Asthma and orbital immunoglobulin G4-related diseaseMisbah Baqir, James A Garrity, Robert Vassallo, et al.
Cancer Research|June 11, 2009
Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphomaZhi-Zhang Yang, Anne J Novak, Steven C Ziesmer, et al.
Blood|July 7, 2007
CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cellsZhi-Zhang Yang, Anne J Novak, Steven C Ziesmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphomaStephen M Ansell, Kay M Ristow, Thomas M Habermann, et al.
Cancer Research|October 19, 2006
Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphomaZhi-Zhang Yang, Anne J Novak, Steven C Ziesmer, et al.
American Journal of Hematology|November 20, 2004
Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of responseIrene M Ghobrial, Daniel Z Uslan, Timothy G Call, et al.
Blood|January 13, 2006
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphomaZhi-Zhang Yang, Anne J Novak, Mary J Stenson, et al.
Pageof 39

Showing results (31-40 of 387) with videos related to

Sort By:
Pageof 39
Medicine|July 16, 2003
Gamma-heavy chain disease: review of 23 casesDietlind L Wahner-Roedler, Thomas E Witzig, Laura L Loehrer, et al.
Blood|April 26, 2003
Expression of CD52 on plasma cells in plasma cell proliferative disordersShaji Kumar, Teresa K Kimlinger, John A Lust, et al.
Leukemia & Lymphoma|November 29, 2013
Therapeutic options for patients with lymphoma and liver dysfunction or failure during mechlorethamine shortageMohamad Bassam Sonbol, Vishal Rana, S Sirop Kenderian, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 20, 2016
Asthma and orbital immunoglobulin G4-related diseaseMisbah Baqir, James A Garrity, Robert Vassallo, et al.
Cancer Research|June 11, 2009
Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphomaZhi-Zhang Yang, Anne J Novak, Steven C Ziesmer, et al.
Blood|July 7, 2007
CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cellsZhi-Zhang Yang, Anne J Novak, Steven C Ziesmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphomaStephen M Ansell, Kay M Ristow, Thomas M Habermann, et al.
Cancer Research|October 19, 2006
Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphomaZhi-Zhang Yang, Anne J Novak, Steven C Ziesmer, et al.
American Journal of Hematology|November 20, 2004
Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of responseIrene M Ghobrial, Daniel Z Uslan, Timothy G Call, et al.
Blood|January 13, 2006
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphomaZhi-Zhang Yang, Anne J Novak, Mary J Stenson, et al.
Pageof 39